Renzo Galanello

Overview

Best Publications

• Beta-thalassemia

  Renzo Galanello;Raffaella Origa

  1666
  Citations

• A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.

  Maria Domenica Cappellini;Alan Cohen;Antonio Piga;Mohamed Bejaoui

  944
  Citations

• Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of β-thalassemia

  Manuela Uda;Renzo Galanello;Serena Sanna;Guillaume Lettre;Guillaume Lettre

  777
  Citations

• A Randomized, Placebo-Controlled, Double-Blind Trial of the Effect of Combined Therapy With Deferoxamine and Deferiprone on Myocardial Iron in Thalassemia Major Using Cardiovascular Magnetic Resonance

  M.A. Tanner;R. Galanello;C. Dessi;G.C. Smith

  614
  Citations

• Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis

  Dudley J Pennell;Vasili Berdoukas;Markissia Karagiorga;Vasili Ladis

  585
  Citations

• On T2* Magnetic Resonance and Cardiac Iron

  John-Paul Carpenter;Taigang He;Paul Kirk;Michael Roughton

  518
  Citations

• Liver iron concentrations and urinary hepcidin in beta-thalassemia.

  Raffaella Origa;Renzo Galanello;Tomas Ganz;Nicolina Giagu

  473
  Citations

• Cardiovascular Function and Treatment in β-Thalassemia Major: A Consensus Statement From the American Heart Association

  Dudley J. Pennell;James E. Udelson;Andrew E. Arai;Biykem Bozkurt

  377
  Citations

• Seventy-five genetic loci influencing the human red blood cell

  Pim Van Der Harst;Weihua Zhang;Irene Mateo Leach;Augusto Rendon

  371
  Citations

• Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload.

  Antonio Piga;Renzo Galanello;Gian Luca Forni;Maria Domenica Cappellini

  371
  Citations

• Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone.

  Alan R. Cohen;Renzo Galanello;Antonio Piga;Vincenzo De Sanctis

  370
  Citations

• Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study

  John Porter;Renzo Galanello;Giuseppe Saglio;Ellis E.J. Neufeld

  319
  Citations

• The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients

  Adriana Ceci;Paola Baiardi;Mariagrazia Felisi;Maria Domenica Cappellini

  280
  Citations

• Safety profile of the oral iron chelator deferiprone: a multicentre study

  Cohen Ar;Galanello R;Piga A;Dipalma A

  275
  Citations

• Healing of broken human chromosomes by the addition of telomeric repeats.

  J Flint;C F Craddock;A Villegas;D P Bentley

  262
  Citations

• Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction.

  Mark A Tanner;Renzo Galanello;Carlo Dessi;Gillian C Smith

  261
  Citations

• Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders

  Emanuele Angelucci;Giovanni Barosi;Clara Camaschella;Maria Domenica Cappellini

  257
  Citations

• Safety, Tolerability, and Pharmacokinetics of ICL670, a New Orally Active Iron-Chelating Agent in Patients with Transfusion-Dependent Iron Overload Due to β-Thalassemia

  Renzo Galanello;Antonio Piga;Daniele Maria Alberti;Marie-Claude Rouan

  252
  Citations

• A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron.

  Maria Antonietta Melis;Milena Cau;Rita Congiu;Gabriella Sole

  234
  Citations

• Seventy-five genetic loci influencing the human red blood cell

  Pim van der Harst;Weihua Zhang;Irene Mateo Leach;Augusto Rendon

  0
  Citations